China's 3D Medicines shines in Hong Kong debut, other newcomers fall
15/12/2022 05:27
** Shares of China's tumor products and candidate drugs
developer 3D Medicines Inc 1244.HK trade as high as HK$32.30
each in Hong Kong debut on Thursday, up 29.3% from offering
price
** Shanghai-based company offered 16.35 mln shares at
HK$24.98 apiece in global offering, raising HK$408.4 mln ($52.51
mln) for research and development, regulatory filings and
commercialization of product urn:newsml:reuters.com:*:nFWN32O1CQ
** CCB International says it prefers innovative medicines
and devices players in healthcare and biotech segment as Chinese
authority is set to accelerate drug approvals, backing a
positive outlook with policy support
** Also a new comer, Chinese snack maker Weilong Delicious
Global 9985.HK slips to HK$10.40 in early afternoon, down 1.5%
from HK$10.56 apiece offering price
** Weilong sold 96.4 mln shares in its global offering,
raising $130.6 mln to expand production facilities, distribution
network and for brand building urn:newsml:reuters.com:*:nL1N32Y0OP
** Zhejiang-based autoparts maker Buyang International
2457.HK , which raised HK$125 mln ($16.1 mln) for production
expansion, drops as much as 30% to HK$0.35 each on debut vs
HK$0.50 offering price urn:newsml:reuters.com:*:nFWN3332P3
** Hang Seng Commerce & Industry Index .HSNC falls 1.9%,
Hang Seng Composite Index .HSCI eases 1.4% while Hang Seng
Index .HSI down 1.3%
($1 = 7.7769 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))